Assistenza infermieristica e carcinoma tiroideo differenziato

Introduzione all’assistenza infermieristica ed al carcinoma tiroideo differenziato

Bibliografia carcinoma

1. Guernsey D.L., Edeleman I.S., “Regulation of Thyroid thermogenesis by thyroid hormones”,Samuels H.H.,1983

2. Megner J.A., “Thhyroid-stimulating hormone:Biosynthesis,cell biology,and bioactivity”,Endocr.Rev. 1990

3. Rassu S.,”Principi generali di endocrinologia”. 1983

4. Christensen S, Ericsson U, Jazon L.” The prevalence of thyroid disorders in a middle- aged population” Chir Scand 1984

5. Tan GH, Gharib H. “Thyroid incidentalomas: management approches to nonpalpable nodules discovered incidentally on thyroid imaging”. Ann Int Med 1997

6. Zanetti R, Crosignani P. “Il cancro in Italia. I dati di incidenza dei Registri Tumori. Lega italiana per la lotta contro i tumori”. Torino Associazione Italiana di Epidemiologia; 1992

7. Ravetto C, Spreafico L, Colombo L.”L’esame citologico con agospirato nella diagnosi precoce delle neoplasie tiroidee”. Prog Med 1995

8. Giovanella L.” I tumori della tiroide”. Marzo 2001

9. DeGroot LJ, Paloyan E.” Thyroid carcinoma and radiation”. JAMA 1999

10. Galanti MR, Ekbom A, Grimelius L.” Parental cancer and risk of papillary and follicular thyroid carcinoma”. Br J Cancer,1997

11. Mazzaferri EL & Kloos RT.”Current approaches to primary therapy for papillary and follicular thyroid cancer” J. Clin. Endocrinol. Metab, 2001

12. Lenziardi M., Fiorini I.”Linee guida per le malattie della tiroide”. Novembre 2001

13. Schlumberger MJ. “Papillary and follicular thyroid carcinoma”. N Engl J Med, 1988

14. AJCC Cancer Staging Manual, 6th edition. New York: Springer-Verlag, 2002

15. Maxon HR, Englaro EE, Thomas SR.” Radioiodine-131 therapy for well differentiated thyroid cancer – a quantitative radiation dosimetric approach”, J Nucl Med 1992

16. Maxon HR, Thomas SR, Samaratunga RC,”Dosimetric considerations in the radio iodine treatment of macrometastases and micrometastases from differentiated thyroid cancer”. Thyroid 1997

17. M Schlumberger, F De Vathaire, C Ceccarelli, MJ Delisle, C Francese, JE Couette, A Pinchera,”Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients”. J Nucl Med 1996

18. Liel Y.”Preparation for radioactive iodine administration in differentiated thyroid cancer patients Clinical Endocrinology”, 2002

19. Thomas C.G. “Role of thyroid stimulating hormone suppression in the management of thyroid cancer”.Seminary Surgical Oncology,1991

20. Haugen BR, Pacini F, Reiners C, Schlumberger M, Ladenson PW, Sherman SI, Cooper DS, Mazzaferri EL, Daniels GS, Ross DS, Cavalieri RR, Spencer CA,” A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol. Metab Ec,1999

21. Ladenson PW, Braverman LE, Mazzaferri EL,” Comparison of administration of recombinant human thyrotropin with withdrawal of thryoid hormone for radioactive iodine scanning in patients with thyroid carcinoma”. N Engl J Med,1997

22. Meier CA, Braverman LE, Ebner SA et al.” Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma”, J Clin Endocrinol Metab, 1994

23. Robbins RJ, Tuttle RM, Sharaf RN, Larson SM, Robbins HK, Ghossein RA, Smith A, Drucker WD,”Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma”. J Clin Endocrinol Metab,2001

24. Torlontano M.,Crocetti U,.D’Aloiso L.,Bonfitto N.,Frusciante V.,Filetti S.,Shumblerger M.,”Serum thyroglobulin and 131 I I whole body scan after recombinant human TSH stimulation in the follw-up of patients with differentiated thyroid carncer”,European Journal of Endocrinology,2003

25. Werga P, Wallin G, Skoog L, Hamberger B. “Expanding role of fine-needle aspiration citology in thyroid dia gnosis and management. “World J Surg 2000

26. Ashcroft MW, Van Herle AJ. “Management of thyroid nodules. II. Scanning techniques, thyroid suppressive therapy, and fine needle aspiration”. Head Neck Surg,1993

27. Singer PA., Cooper DS, Daniels GH, Ladenson PW, Greespan FS, Levy EG et al. “Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer”. Arch Int Med 1996

28. Maxon.”Quantitative radioiodine therapy in the treatment of differentiated thyroid cancer “, QJ Nucl Med 1999

29. Tsang RW, Brierley JD, Simpson WJ et al. “The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma”. Cancer 1998

30. “Assistenza infermieristica avanzata”;;Schober Madrean, Affara Fadwa .Editore CEA, 2008

31. “Il codice dell’infermiere”; Venturi Emiliano,Edit Mondostudio;2008

32. “Le competenze degli infermieri in sala operatoria. Guida alla valutazione e ai percorsi formativi “,Lusa Anna, Edit Franco Angeli, 2008

33. “ Assistenza infermieristica perioperatoria”;Wicker Paul,O’Neill Joy;Editore McGraw-Hill Companies, 2007

34. “Gestione del team infermieristico. Strumenti e metodologie”; Esposito Mario; Editore: Hoepli, 2007

35. “Principi fondamentali dell’assistenza infermieristica”; Craven Ruth F. – Hirnle Constance J.;Edit.CEA, 2007

36. “Le complicanze maggiori della chirurgia tiroidea”; Bastagli,Amelia,Alba, 2003

37. Dalla Medline Minerva Endocrinol” Total thyroidectomy in the surgical treatment of thyroid disease a retrospective clinical study”, 2001

38. Medline: World J Surg,” Palpatory method used to identify the recurrent laryngeal nerve during thyroidectomy” May 2000

39. ”Fossart G.H.,Clark O.H.,”Thyroid and parathyroid procedures”;in ACS Surgery;Principles and practice,WebMD corporation,2001

40. P Tran Ba Huy;”Tiroidectomie”;Encycl Med Chir,2001

41. P Miccoli,P Iacconi;”Chirurgia del collo”,UTET 2004

42. Lebollueux S,et al “The role of follw-up of patients treated for differentiated epithelial thyroid cancers”;Nature Clin Pract Endocr&Metabol,2007

43. Söderström N., Telenius-Berg M., Akerman M.; ”Diagnosis of medullary carcinoma of the thyroid by fine needle aspiration biopsy”. Acta med. Scand 1995

44. Megner J.A,”Thyroid-stimulating hormone:Biosynthesis,cell biology,and bioactivity”,Endocr.Rev. 1990

45. Barbaro D,Simi U,Lopane P,Pallini S,Orsini P,Piazza F,Pasquini C,Soriani G.”Thyroid nodules with microfollicular findings reported on fine needle aspiration:invariably surgical treatment” Endocr Pract,2001

46. Cole ES,Lee K,Lauziere K,et al. “Recombinant human thyroid stimulating hormone:development of a biotechnology product for detection of metastatic lesions of thyroid carcinoma.”;Bio technology 1993

47. Down Kh,Ferrel BR,Anello C,”.Quality of life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy”.Thyroid 1999

48. Shumberger M et al “Follow-up of low-risk patients with differentiated thyroid carcinoma:a European perspective”.Eur J Endocrinol 2004

49. Shammas A,et al “Therapy in patients with suspected recurrent or metastatic well-differentiated thyroid cancer”;J Nucl Med,2007

50. Kumagai A,Reiners C,Drozd V,Yamashita S.”Thyroid Cancer and Radioactive Iodine Therapy:necessity of precautious Radiation Health Risk Management”;Endocr J,2007

51. McCaffrey TV, Bergstralh EJ, Hay ID. “Locally invasive papillary thyroid carcinoma” 1940-1990

52. Nishida T, Nakao K, Hamaji M, Kamiike W, Kurozumi K, Matsuda H. “Preservation of recurrent laryngeal nerve invaded by differentiated thyroid cancer”. Ann Surg 1997

53. Noguchi M, Kinami S, Kinoshita K, Kitagawa H, Thomas M, Miyazaki I, Michigishi T, Mizukami Y. “Risk of bilateral cervical lymph node metastases in papillary thyroid cancer”

54. Pacini F, Lari R, Mazzeo S, Grasso L, Taddei D, Pinchera A. “Diagnostic value of a single serum of thyroglobulin determination on and off thyroid suppressive therapy in the follow-up of patients with differentiated thyroid cancer” Clin. Endocrinol. 1985

55. Scheumann GF, Gimm O, Wegener G, Hundeshagen H, Dralle H. “Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer”. World J Surg. 1994

56. Schlumberger M, Mancusi F, Baudin E, Pacini F. “131I therapy for elevated thyroglobulin levels. Thyroid”1997

57. Bernier MO, Leenhardt L, Hoang C et al. “Survival and therapeutic modalities in patients with metastases of differentiated thyroid carcinomas. “J Clin Endocrinol Metab. 2001

58. Kebebew E, Clark OH. “Differentiated thyroid cancer: complete rational approach.” World J Surg. 2000

59. Kowalski LP, Filho JG. “Results of the treatment of locally invasive thyroid carcinoma”. Head Neck. 2002

60. Mazzaferri EL, Kloos RT.“diagnostic iodine-131 scanning with recombinant human TSH useful in the follow- up of differentiated thyroid cancer after thyroid ablation”; J Clin Endocrinol Metab. 2002

Autore: Sara

Condividi questo articolo su

1 Commento

Invia commento

Il tuo indirizzo email non sarà pubblicato.